Production (Stage)
NanoSphere Health Sciences Inc.
NSHS
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.80K | 2.00K | 11.80K | 22.70K | 8.10K |
| Total Receivables | 12.20K | 11.60K | 11.10K | 10.30K | 9.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.00K | 13.60K | 22.90K | 33.00K | 17.90K |
|
|
|||||
| Total Current Assets | 14.00K | 13.60K | 22.90K | 33.00K | 17.90K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.00K | 13.60K | 22.90K | 33.00K | 17.90K |
|
|
|||||
| Total Accounts Payable | 601.90K | 594.50K | 1.08M | 1.07M | 1.06M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 35.00K | 30.70K | 32.00K | 30.80K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 692.10K | 605.60K | 590.60K | 558.80K | 531.60K |
| Total Other Current Liabilities | 692.10K | 605.60K | 590.60K | 558.80K | 531.60K |
| Total Current Liabilities | 1.33M | 1.23M | 1.71M | 1.66M | 1.60M |
|
|
|||||
| Total Current Liabilities | 1.33M | 1.23M | 1.71M | 1.66M | 1.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 35.00K | 30.70K | 32.00K | 30.80K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.33M | 1.23M | 1.71M | 1.66M | 1.60M |
|
|
|||||
| Common Stock & APIC | 18.76M | 18.76M | 18.76M | 18.76M | 18.76M |
| Retained Earnings | -21.38M | -21.28M | -21.69M | -21.65M | -21.55M |
| Treasury Stock & Other | 1.30M | 1.30M | 1.24M | 1.26M | 1.21M |
| Total Common Equity | -1.32M | -1.22M | -1.68M | -1.63M | -1.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.32M | -1.22M | -1.68M | -1.63M | -1.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.32M | -1.22M | -1.68M | -1.63M | -1.58M |
|
|
|||||